Posterior Vitreomacular Adhesion: A Potential Risk Factor for Exudative Age-related Macular Degeneration?

American Journal of Ophthalmology

Volumn 144, Issue 5, 2007, Pages

  Krebs, Ilse ^a,b   Brannath, Werner ^c   Glittenberg, Carl ^b   Zeiler, Florian ^b   Sebag, Jerry ^d   Binder, Susanne ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FREE RADICAL;

ADULT; AGED; ARTICLE; B SCAN; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RISK FACTOR; TISSUE OXYGENATION; VITREOUS BODY DETACHMENT;

EID: 35349014156     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.07.024     Document Type: Article

References (36)

1. Spaide R.F., Armstrong D., and Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration-what is the cause?. Retina 23 (2003) 595-614
2. Ito Y., Terasaki H., Suzuki T., et al. Mapping posterior vitreous detachment by optical coherence tomography in eyes with idiopathic macular hole. Am J Ophthalmol 135 (2003) 351-355
3. Gaudric A., Haouchine B., Massin P., Paques M., Blain P., and Erginay A. Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol 117 (1999) 744-751
4. Johnson M.W. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc 103 (2005) 537-567
5. Sebag J. Vitreous-from biochemistry to clinical relevance. Chap 16. In: Tasman W., and Jaeger E.A. (Eds). Duane's foundations of clinical ophthalmology Vol 1 (1998), Lippincott Williams & Wilkins, Philadelphia, Pennsylvania
6. Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 225 (1987) 89-93
7. Sebag J. Age-related differences in the human vitreo-retinal interface. Arch Ophthalmol 109 (1991) 966-971
8. Ondes F., Yilmaz G., Acar M.A., Unlu N., Kocaoglan H., and Arsan A.K. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol 44 (2000) 91-93
9. Weber-Krause B., and Eckardt C. [Incidence of posterior vitreous detachment in the elderly]. Ophthalmologe 94 (1997) 619-623
10. Davis M.D., Gangnon R.E., Lee L.Y., et al., Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123 (2005) 1484-1498
11. Ferris F.L., Davis M.D., Clemons T.E., et al., Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123 (2005) 1570-1574
12. White H. Maximum likelihood estimation of misspecified models. Econometrica 50 (1982) 1-25
13. Foos R.Y. Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol 76 (1972) 480-497
14. Binder S., Krebs I., Hilgers R.D., et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci 45 (2004) 4151-4160
15. Clemons T.E., Milton R.C., Klein R., Seddon J.M., Ferris III F.L., and Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 19. Ophthalmology 112 (2005) 533-539
16. Chakravarthy U., Augood C., Bentham G.C., et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114 (2007) 1157-1163
17. Francis P.J., George S., Schultz D.W., et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 63 (2007) 212-218
18. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study (AREDS) Report No. 3. Ophthalmology 107 (2000) 2224-2232
19. Hammond C.J., Webster A.R., Snieder H., Bird A.C., Gilbert C.E., and Spector T.D. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 109 (2002) 730-736
20. Seddon J.M., Cote J., Page W.F., Aggen S.H., and Neale M.C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123 (2005) 321-327
21. Seddon J.M., George S., and Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol 124 (2006) 995-1001
22. Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 242 (2004) 690-698
23. Anderson D.H., Mullins R.F., Hageman G.S., and Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134 (2002) 411-431
24. Donoso L.A., Kim D., Frost A., Callahan A., and Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51 (2006) 137-152
25. Zarbin M.A.S. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122 (2004) 598-614
26. Sebag J., and Hageman G.S. Interfaces. Eur J Ophthalmol 10 (2000) 1-3
27. Adamis A.P., and Shima D.T. The role of vascular endothelial growth factor in ocular health and disease. Retina 25 (2005) 111-118
28. Bishop P.N., Holmes D.F., Kadler K.E., McLeod D., and Bos K.J. Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci 45 (2004) 1041-1046
29. Sebag J. Diabetic vitreopathy. Ophthalmology 103 (1996) 205-206
30. Sebag J., Nie S., Reiser K.A., Charles M.A., and Yu N.T. Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 35 (1994) 2976-2980
31. Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol 231 (1993) 257-260
32. Stitt A.W. The Maillard reaction in eye diseases. Ann N Y Acad Sci 1043 (2005) 582-597
33. Jalkh A., Takahashi M., Topilow H.W., et al. Prognostic value of vitreous findings in diabetic retinopathy. Arch Ophthalmol 100 (1982) 432-434
34. Sebag J. Pharmacologic vitreolysis. Retina 18 (1998) 1-3
35. Sebag J. Is pharmacologic vitreolysis brewing?. Retina 22 (2002) 1-3
36. Sebag J. Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc 103 (2005) 473-494